Literature DB >> 25752487

Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease?

Seung In Seo1, Sung Jun Kim1, Hyoung Su Kim1, Woon Geon Shin1, Kyung Ho Kim1, Myoung Kuk Jang1, Jin Heon Lee1, Hak Yang Kim1.   

Abstract

BACKGROUND: The eradication rate of Helicobacter pylori (H. pylori) infection might be affected by the degree of inflammation of gastric mucosa represented by the endoscopic stage of peptic ulcer disease (PUD). The aims of this study were to evaluate the eradication rates of H. pylori infection according to the endoscopic stage of PUD and to document whether early eradication in the active stage could yield a higher eradication rate in patients with peptic ulcer bleeding (PUB).
MATERIALS AND METHODS: A total of 1,177 patients with PUD (380 gastric ulcer, 710 duodenal ulcer, and 87 combined ulcer) who received proton-pump inhibitor (PPI)-based triple therapy were included, and the eradication rates were compared by ulcer stage. Univariate and multivariate analyses were conducted to identify factors influencing eradication rate. In PUB, the eradication rates between the early eradication group (≤7 days) and the late eradication group (>7 days) were compared.
RESULTS: The eradication rates according to endoscopic stage were significantly different in gastric ulcer (active vs healing vs scarring; 84.8% vs 82.7% vs 70.6%, p = .014, respectively), but there were no significant differences in duodenal ulcer (active vs healing vs scarring; 87.6% vs 80.9%% vs 80.9% p = .169, respectively). In multivariate analyses, active ulcer as well as age younger than 50 was a significantly independent predictor of successful eradication (Odds ratio; 2.799, 95% CI; 1.659-4.723, p = .0001). The eradication rate of the early eradication group was significantly higher than the late eradication group in PUB (89.2% vs 71.9%, 95% CI; 1.265-8.269, p = .011).
CONCLUSIONS: There was a significant difference in the eradication rate according to the endoscopic stage of gastric ulcer. Active ulcer was an independent predictor of successful eradication. Furthermore, early H. pylori eradication should be considered in patients with PUB to yield a higher eradication rate.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter pylori; eradication; stage; ulcer

Mesh:

Substances:

Year:  2015        PMID: 25752487     DOI: 10.1111/hel.12221

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes.

Authors:  Masoud Alebouyeh; Abbas Yadegar; Nastaran Farzi; Marzyieh Miri; Homayoon Zojaji; Somayeh Gharibi; Zeinab Fazeli; Naser Ebrahimi Daryani; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

2.  Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates.

Authors:  Cheal Wung Huh; Young Hoon Youn; Da Hyun Jung; Jae Jun Park; Jie-Hyun Kim; Hyojin Park
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

3.  Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection.

Authors:  Jae Hyun Jung; In Kuk Cho; Chang Hee Lee; Gwan Gyu Song; Ji Hyun Lim
Journal:  Gut Liver       Date:  2018-03-15       Impact factor: 4.519

4.  Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.

Authors:  Yanbo Tang; Guodu Tang; Liying Pan; Hua Zhu; Shanmei Zhou; Zhaoyong Wei
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

5.  Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.

Authors:  Junxian Wang; Yuping Cao; Wei He; Xiaoping Li
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

6.  The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori.

Authors:  Seung Woo Lee; Sung Jin Moon; Sae Hee Kim; Sung Hee Jung; Kyung Ho Song; Sun Moon Kim; Jae Kyu Sung; Dong Soo Lee
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.